Beijing Hotgen Biotech Co Ltd (688068) — Cash Flow Reinvestment Rate
Beijing Hotgen Biotech Co Ltd (688068) has a Cash Flow Reinvestment Rate of 4.82x as of September 2025, reinvesting CN¥14.73 Million (capex CN¥14.73 Million ) from operating cash flow of CN¥3.05 Million. Explore 688068 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Hotgen Biotech Co Ltd Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for Beijing Hotgen Biotech Co Ltd across 7 annual periods. Also explore balance sheet size of Beijing Hotgen Biotech Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Beijing Hotgen Biotech Co Ltd (2016–2022)
Year-by-year capital reinvestment analysis for Beijing Hotgen Biotech Co Ltd. For live market cap and broader valuation context, see how much is Beijing Hotgen Biotech Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.73x | CN¥1.70 Billion | CN¥978.75 Million | CN¥565.21 Million | ▲ +159.5% |
| 2021 | 0.67x | CN¥1.77 Billion | CN¥2.64 Billion | CN¥398.86 Million | ▼ -92.9% |
| 2020 | 9.35x | CN¥1.54 Billion | CN¥164.62 Million | CN¥172.27 Million | ▼ -87.6% |
| 2019 | 75.11x | CN¥1.45 Billion | CN¥19.37 Million | CN¥88.48 Million | ▲ +193.5% |
| 2018 | 25.59x | CN¥1.41 Billion | CN¥55.04 Million | CN¥42.00 Million | ▲ +330.0% |
| 2017 | 5.95x | CN¥136.61 Million | CN¥22.95 Million | CN¥69.05 Million | ▲ +546.2% |
| 2016 | 0.92x | CN¥41.95 Million | CN¥45.54 Million | CN¥21.18 Million | — |